• In Q4-2021 (ended October 2021), the company recalled outdated versions of its products, and started replacing with updated versions. As a result, revenue declined from $1.31M in Q3, to $0.40M in Q4, and $0.47M in Q1-2022 (ended January 2022). Q1 revenue was 77% below our estimate. Shares are down 49% YTD.
        • This report is currently available to premium subscribers – Free subscribers will gain access on May 10, 2022
          Join as a FREE member and get our research report delivered straight to your inbox, with a seven-day delay

Visit TAAT Global Alternatives Inc. page for more research, discussion boards and to like, and share.

Are you enjoying the highlights?

Discover the company's fair value estimate from our certified analysts, identify potential risks, and explore exciting upcoming catalysts in our detailed report.

Already a member? Sign In